Sagimet Biosciences Inc. (NASDAQ: SGMT) reported Q2 EPS of ($35.80), $35.29 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Sagimet Biosciences Inc. (SGMT) click here.